Bridges Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Bridges Investment Management's GILD Position: Q1 2020 in Review
Bridges Investment Management sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 6,843 shares — an estimated $445K sold.
Bridges Investment Management first reported a position in GILD in Q4 2013 and held it in 25 quarters. The position peaked at $10.1M in Q3 2018. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.
- Bridges Investment Management reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
- Bridges Investment Management sold 6,843 Gilead Sciences shares in Q1 2020, an estimated $445K.
- Bridges Investment Management first reported a position in Gilead Sciences in Q4 2013 and held it in 25 quarters.
- Bridges Investment Management's Gilead Sciences position peaked at $10.1M in Q3 2018.
- 1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.
Based on Bridges Investment Management's 13F filing for Q1 2020, filed 12 May 2020.